---
figid: PMC3446326__bcr3139-1
figtitle: Alterations in the FGFR signalling pathway that influence breast cancer
organisms:
- Homo sapiens
- Mus musculus
- Xenopus laevis
- Mouse mammary tumor virus
organisms_ner:
- Homo sapiens
- Mus musculus
- Xenopus laevis
pmcid: PMC3446326
filename: bcr3139-1.jpg
figlink: /pmc/articles/PMC3446326/figure/F1/
number: F1
caption: Alterations in the FGFR signalling pathway that influence breast cancer.
  Single nucleotide polymorphisms (SNPs) influence breast cancer risk (FGFR2), and
  prognosis in established cancers likely through effects on motility and invasive
  capacity (FGFR4). Somatic alterations presenting potential therapeutic targets include
  amplification of FGFR1 and FGFR2, and aberrant FGF2 ligand expressed in a paracrine
  or autocrine fashion.
papertitle: Challenges and opportunities in the targeting of fibroblast growth factor
  receptors in breast cancer.
reftext: Vikram K Jain, et al. Breast Cancer Res. 2012;14(3):208-208.
year: '2012'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8642765
figid_alias: PMC3446326__F1
figtype: Figure
redirect_from: /figures/PMC3446326__F1
ndex: cd550c14-df1d-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3446326__bcr3139-1.html
  '@type': Dataset
  description: Alterations in the FGFR signalling pathway that influence breast cancer.
    Single nucleotide polymorphisms (SNPs) influence breast cancer risk (FGFR2), and
    prognosis in established cancers likely through effects on motility and invasive
    capacity (FGFR4). Somatic alterations presenting potential therapeutic targets
    include amplification of FGFR1 and FGFR2, and aberrant FGF2 ligand expressed in
    a paracrine or autocrine fashion.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FGF1
  - FGF2
  - FGF3
  - FGF4
  - FGF5
  - FGF6
  - FGF7
  - FGF8
  - FGF9
  - FGF10
  - FGF11
  - FGF12
  - FGF13
  - FGF14
  - FGF16
  - FGF17
  - FGF18
  - FGF19
  - FGF20
  - FGF21
  - FGF22
  - FGF23
  - FGFR2
  - FGFR1
  - FGFR4
  - Fgfr2
  - Fgfr1
  - Fgfr4
  - fgfr2.L
  - fgfr2.S
  - fgfr1.S
  - fgfr1.L
  - fgfr4.L
  - fgfr4.S
---
